Better Buy: AbbVie Inc. vs. Eli Lilly

Which drug stock wins in a head-to-head match-up between AbbVie and Eli Lilly?

At the beginning of 2016, AbbVie (NYSE:ABBV) and Eli Lilly (NYSE:LLY) were nearly exactly the same size in terms of market cap. However, AbbVie's stock outperformed Lilly throughout most of the year, making AbbVie the bigger company now.

Size doesn't matter much, though, when it comes to selecting the better stock for the future. The important things are each company's product lineup, pipeline potential, and financial condition. Here's how AbbVie and Eli Lilly compare on these key criteria.

No comments:

Post a Comment

Forget Rising Rates. 5 Great REITs To Buy Today

Some REITs have what it takes to outperform in this sort of environment Real estate investment trusts (REITs) have really take...